Revolve Surgical wins FDA clearance for surgical robot

Revolve Surgical announced today that it received FDA 510(k) clearance for its surgical robot platform.

The Canada-based company develops what it describes as a first-in-class, zero-footprint surgical platform. It provides robotic assistance to augment surgeons performing soft tissue procedures.

Revolve says its table-mounted system can integrate into existing clinical workflows. Backed by Y Combinator, Revolve states that its ultimate goal is to enable physical AI in operating rooms at scale.

Sign up for Blog Updates